Back to search

Molecule Structure

Scientific Name


Description of the Drug

Pacritinib is a kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

Cti Biopharma Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tyrosine-protein kinase receptor FLT3 SINGLE PROTEIN INHIBITOR CHEMBL1974
Tyrosine-protein kinase JAK2 SINGLE PROTEIN INHIBITOR CHEMBL2971

Unichem Links

DrugBank DB11697
PubChem: Thomson Pharma 104174247
PubChem 46216796
PDBe 6T3
BindingDB 50210177
Brenda 27071
ChemicalBook CB82628224
Guide to Pharmacology 7793
ZINC ZINC000043153645